Infliximab therapy provides beneficial effects for choroidal thickness increase in patients with active ankylosing spondylitis: A possible mechanism mediating the suppressing of uveitis attacks

Creative Commons License

KARKUCAK M., KOLA M., Kalkisim A., ÇAPKIN E., AYAR A., TÜRK A.

ARCHIVES OF RHEUMATOLOGY, cilt.36, sa.1, ss.56-62, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 36 Sayı: 1
  • Basım Tarihi: 2021
  • Doi Numarası: 10.46497/archrheumatol.2021.7806
  • Dergi Adı: ARCHIVES OF RHEUMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.56-62
  • Anahtar Kelimeler: Ankylosing spondylitis, choroid thickness, infliximab, optical coherence tomography, retinal nerve fiber layer thickness, OPTICAL COHERENCE TOMOGRAPHY, NERVE-FIBER LAYER, ARTERIAL STIFFNESS, ALPHA THERAPY, RECOMMENDATIONS, ASSOCIATION, EYES
  • Karadeniz Teknik Üniversitesi Adresli: Evet

Özet

Objectives: This study aims to quantitatively assess the profile of the choroidal thickness (ChT) in patients with ankylosing spondylitis (AS) using optical coherence tomography (OCT), and to examine whether the posterior eye segment abnormalities in active AS patients are reversible by infliximab therapy.